{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:17:21Z","timestamp":1787584641552,"version":"build-2736575974"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00228-015-1835-x","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T20:39:29Z","timestamp":1428007169000},"page":"569-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Gynecomastia and drugs: a critical evaluation of the literature"],"prefix":"10.1007","volume":"71","author":[{"given":"Frank Q.","family":"Nuttall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit S.","family":"Warrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Gannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"1835_CR1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-48-2-338","volume":"48","author":"F Nuttall","year":"1979","unstructured":"Nuttall F (1979) Gynecomastia as a physical finding in normal man. J Clin Endocrinol Metab 48:338\u2013340","journal-title":"J Clin Endocrinol Metab"},{"key":"1835_CR2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM198010023031405","volume":"303","author":"HE Carlson","year":"1980","unstructured":"Carlson HE (1980) Gynecomastia. N Engl J Med 303:795\u2013799","journal-title":"N Engl J Med"},{"key":"1835_CR3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1056\/NEJM199302183280708","volume":"328","author":"GD Braunstein","year":"1993","unstructured":"Braunstein GD (1993) Gynecomastia. N Engl J Med 328:490\u2013495","journal-title":"N Engl J Med"},{"key":"1835_CR4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(84)90353-X","volume":"77","author":"CB Niewoehner","year":"1984","unstructured":"Niewoehner CB, Nuttall FQ (1984) Gynecomastia in a hospitalized male population. Am J Med 77:633\u2013638","journal-title":"Am J Med"},{"key":"1835_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s101570300014","volume":"7","author":"N Komine","year":"2003","unstructured":"Komine N, Takeda Y, Nakamata T (2003) Amlodipine-induced gynecomastia in two patients on long-term hemodialysis therapy. Clin Exp Nephrol 7:85\u201386","journal-title":"Clin Exp Nephrol"},{"key":"1835_CR6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.5694\/j.1326-5377.1994.tb125970.x","volume":"160","author":"J Zochling","year":"1994","unstructured":"Zochling J, Large G, Fassett R (1994) Gynaecomastia and amlodipine. Med J Aust 160:807","journal-title":"Med J Aust"},{"key":"1835_CR7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1592\/phco.26.8.1165","volume":"26","author":"KB Hammons","year":"2006","unstructured":"Hammons KB, Edwards RF, Rice WY (2006) Golf-inhibiting gynecomastia associated with atorvastatin therapy. Pharmacotherapy 26:1165\u20131168","journal-title":"Pharmacotherapy"},{"key":"1835_CR8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1445-5994.2002.00323.x","volume":"33","author":"BD Fredericks","year":"2003","unstructured":"Fredericks BD, Lepre F (2003) Benserazide-induced gynaecomastia. Intern Med J 33:54\u201355","journal-title":"Intern Med J"},{"key":"1835_CR9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.300.6723.541","volume":"300","author":"Y Nakamura","year":"1990","unstructured":"Nakamura Y, Yoshimoto K, Saima S (1990) Gynaecomastia induced by angiotensin converting enzyme inhibitor. BMJ 300:541","journal-title":"BMJ"},{"key":"1835_CR10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/bmj.296.6631.1262-c","volume":"296","author":"HM Markusse","year":"1988","unstructured":"Markusse HM, Meyboom RH (1988) Gynaecomastia associated with captopril. Br Med J (Clin Res Ed) 296:1262\u20131263","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1835_CR11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/gut.20.2.154","volume":"20","author":"RW Spence","year":"1979","unstructured":"Spence RW, Celestin LR (1979) Gynaecomastia associated with cimetidine. Gut 20:154\u2013157","journal-title":"Gut"},{"key":"1835_CR12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198304143081508","volume":"308","author":"RT Jensen","year":"1983","unstructured":"Jensen RT, Collen MJ, Pandol SJ et al (1983) Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states. N Engl J Med 308:883\u2013887. doi: 10.1007\/s00228-015-1835-x","journal-title":"N Engl J Med"},{"key":"1835_CR13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/bmj.308.6927.503","volume":"308","author":"LA Garcia Rodriguez","year":"1994","unstructured":"Garcia Rodriguez LA, Jick H (1994) Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ 308:503\u2013506","journal-title":"BMJ"},{"key":"1835_CR14","first-page":"90","volume":"77","author":"RT Jensen","year":"1984","unstructured":"Jensen RT, Collen MJ, McArthur KE, Howard JM, Maton PN, Cherner JA, Gardner JD (1984) Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with Gastric Hypersecretory States. Am J Med 77:90\u2013105","journal-title":"Am J Med"},{"key":"1835_CR15","first-page":"841","volume":"295","author":"WH Hall","year":"1976","unstructured":"Hall WH (1976) Breast changes in males on cimetidine. N Engl J Med 295:841","journal-title":"N Engl J Med"},{"key":"1835_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/10428190109097699","volume":"42","author":"D Abhyankar","year":"2001","unstructured":"Abhyankar D, Saikia T, Advani S (2001) Gynecomastia in a case of hairy cell leukaemia\u2013cladribine induced? Leuk Lymphoma 42:243\u2013246","journal-title":"Leuk Lymphoma"},{"key":"1835_CR17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archinte.1982.00340180054012","volume":"142","author":"AR Turner","year":"1982","unstructured":"Turner AR, Morrish DW, Berry J, MacDonald RN (1982) Gynecomastia after cytotoxic therapy for metastatic testicular cancer. Arch Intern Med 142:896\u2013897","journal-title":"Arch Intern Med"},{"key":"1835_CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archinte.1982.00340160091020","volume":"142","author":"DL Trump","year":"1982","unstructured":"Trump DL, Pavy MD, Staal S (1982) Gynecomastia in men following antineoplastic therapy. Arch Intern Med 142:511\u2013513","journal-title":"Arch Intern Med"},{"key":"1835_CR19","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archinte.1979.03630460080023","volume":"139","author":"AR Glass","year":"1979","unstructured":"Glass AR, Berenberg J (1979) Gynecomastia after chemotherapy for lymphoma. Arch Intern Med 139:1048\u20131049","journal-title":"Arch Intern Med"},{"key":"1835_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.1983.158","volume":"48","author":"DM Large","year":"1983","unstructured":"Large DM, Jones JM, Shalet SM et al (1983) Gynaecomastia complicating the treatment of myeloma. Br J Cancer 48:69\u201374","journal-title":"Br J Cancer"},{"key":"1835_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5858\/2002-126-0613-GWMCAA","volume":"126","author":"YY Jun","year":"2002","unstructured":"Jun YY (2002) Gynecomastia with marked cellular atypia associated with chemotherapy. Arch Pathol Lab Med 126:613\u2013614","journal-title":"Arch Pathol Lab Med"},{"key":"1835_CR22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000068762","volume":"70","author":"MC Uygur","year":"2003","unstructured":"Uygur MC, Ozen H (2003) Gynecomastia following chemotherapy for testicular cancer. Urol Int 70:253\u2013254","journal-title":"Urol Int"},{"key":"1835_CR23","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.transproceed.2005.06.019","volume":"37","author":"G Iaria","year":"2005","unstructured":"Iaria G, Urbani L, Catalano G, De Simone P, Carrai P, Petruccelli S, Morelli L, Coletti L, Garcia C, Liermann R, Mosca F, Filipponi F (2005) Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients. Transplant Proc 37:2632\u20132633","journal-title":"Transplant Proc"},{"key":"1835_CR24","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/leu.2008.106","volume":"22","author":"G Caocci","year":"2008","unstructured":"Caocci G, Atzeni S, Orru N et al (2008) Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia. Leukemia 22:2127\u20132128","journal-title":"Leukemia"},{"key":"1835_CR25","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(79)91973-1","volume":"1","author":"HJ Moerck","year":"1979","unstructured":"Moerck HJ, Magelund G (1979) Gynaecomastia and diazepam abuse. Lancet 1:1344\u20131345","journal-title":"Lancet"},{"key":"1835_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1345\/aph.1E294","volume":"39","author":"AV Jelenkovic","year":"2005","unstructured":"Jelenkovic AV, Macukanovic-Golubovic L (2005) Diazepam-associated gynecomastia. Ann Pharmacother 39:201","journal-title":"Ann Pharmacother"},{"key":"1835_CR27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/106002809402800521","volume":"28","author":"R Llop","year":"1994","unstructured":"Llop R, Gomez-Farran F, Figueras A, Capella D, Laporte J-R (1994) Gynecomastia associated with enalapril and diazepam. Ann Phamacother 28:671\u2013672","journal-title":"Ann Phamacother"},{"key":"1835_CR28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1258\/0956462011923390","volume":"12","author":"C Aquilina","year":"2001","unstructured":"Aquilina C, Viraben R (2001) Gynaecomastia in a male patient during stavudine and didanosine treatment for HIV infection. Int J STD AIDS 12:481\u2013482","journal-title":"Int J STD AIDS"},{"key":"1835_CR29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/bmj.3.5929.520-b","volume":"3","author":"JF Bridgman","year":"1974","unstructured":"Bridgman JF, Buckler JM (1974) Letter: drug-induced gynaecomastia. Br Med J 3:520\u2013521","journal-title":"Br Med J"},{"key":"1835_CR30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/0253-7613.59929","volume":"41","author":"U Aiman","year":"2009","unstructured":"Aiman U, Haseeen MA, Rahman SZ (2009) Gynecomastia: an ADR due to drug interaction. Indian J Pharmacol 41:286\u2013287","journal-title":"Indian J Pharmacol"},{"key":"1835_CR31","first-page":"54","volume":"62","author":"CJ Wolfe","year":"1975","unstructured":"Wolfe CJ (1975) Case report. Gynecomastia following digitalis administration. J Fla Med Assoc 62:54\u201355","journal-title":"J Fla Med Assoc"},{"key":"1835_CR32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archinte.1988.00380020123017","volume":"148","author":"LA Tanner","year":"1988","unstructured":"Tanner LA, Bosco LA (1988) Gynecomastia associated with calcium channel blocker therapy. Arch Intern Med 148:379\u2013380","journal-title":"Arch Intern Med"},{"key":"1835_CR33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archinte.1994.00420030166023","volume":"154","author":"C Otto","year":"1994","unstructured":"Otto C, Richter WO (1994) Unilateral gynecomastia induced by treatment with diltiazem. Arch Intern Med 154:351","journal-title":"Arch Intern Med"},{"key":"1835_CR34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/pgmj.67.786.401-a","volume":"67","author":"JP Keating","year":"1991","unstructured":"Keating JP, Rees M (1991) Gynaecomastia after long-term administration of domperidone. Postgrad Med J 67:401\u2013402","journal-title":"Postgrad Med J"},{"key":"1835_CR35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/bmj.285.6348.1083-a","volume":"285","author":"DM Reid","year":"1982","unstructured":"Reid DM, Martynoga AG, Nuki G (1982) Reversible gynaecomastia associated with D-penicillamine in a man with rheumatoid arthritis. Br Med J (Clin Res Ed) 285:1083\u20131084","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1835_CR36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2133.1989.tb07796.x","volume":"120","author":"AJ Carmichael","year":"1989","unstructured":"Carmichael AJ, Paul CJ (1989) Reversible gynaecomastia associated with etritinate. Br J Dermatol 120:317","journal-title":"Br J Dermatol"},{"key":"1835_CR37","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/00002030-200107270-00018","volume":"15","author":"JA Caso","year":"2001","unstructured":"Caso JA, Prieto Jde M, Casas E, Sanz J (2001) Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. AIDS 15:1447\u20131448","journal-title":"AIDS"},{"key":"1835_CR38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1075-122X.2004.21392.x","volume":"10","author":"F Jover","year":"2004","unstructured":"Jover F, Cuadrado JM, Roig P et al (2004) Efavirenz-associated gynecomastia: report of five cases and review of the literature. Breast J 10:244\u2013246","journal-title":"Breast J"},{"key":"1835_CR39","author":"P Mercie","year":"2001","unstructured":"Mercie P, Viallard JF, Thiebaut R et al (2001) Efavirenz-associated breast hypertrophy in HIV-infection patients. AIDS. doi: 10.1007\/s00228-015-1835-x","journal-title":"AIDS"},{"key":"1835_CR40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00002030-200101050-00021","volume":"15","author":"P Mercie","year":"2001","unstructured":"Mercie P, Viallard JF, Thiebaut R et al (2001) Efavirenz-associated breast hypertrophy in HIV-infection patients. AIDS 15:126\u2013129","journal-title":"AIDS"},{"key":"1835_CR41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1345\/aph.1H475","volume":"41","author":"V Gardette","year":"2007","unstructured":"Gardette V, Vezzosi D, Maiza JC et al (2007) Gynecomastia associated with fenofibrate. Ann Pharmacother 41:508\u2013510","journal-title":"Ann Pharmacother"},{"key":"1835_CR42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00007611-199906000-00012","volume":"92","author":"JA Miller","year":"1999","unstructured":"Miller JA, Pramanik B, Gilhooly P (1999) Waxing and waning gynecomastia: an indication of noncompliant use of prescribed medication. South Med J 92:615\u2013617","journal-title":"South Med J"},{"key":"1835_CR43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/0378-6323.51273","volume":"75","author":"P Mansouri","year":"2009","unstructured":"Mansouri P, Farshi S, Safar F (2009) Finasteride-induced gynecomastia. Indian J Dermatol Venereol Leprol 75:309\u2013310","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1835_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0974-7753.51930","volume":"1","author":"Y Ramot","year":"2009","unstructured":"Ramot Y, Czarnowicki T, Zlotogorski A (2009) Finasteride induced gynecomastia: case report and review of the literature. Int J Trichology 1:27\u201329","journal-title":"Int J Trichology"},{"key":"1835_CR45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1440-0960.2000.00392.x","volume":"41","author":"MS Wade","year":"2000","unstructured":"Wade MS, Sinclair RD (2000) Reversible painful gynaecomastia induced by low dose finasteride (1 mg\/day). Australas J Dermatol 41:55","journal-title":"Australas J Dermatol"},{"key":"1835_CR46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.138.4.533","volume":"138","author":"J Ferrando","year":"2002","unstructured":"Ferrando J, Grimalt R, Alsina M et al (2002) Unilateral gynecomastia induced by treatment with 1 mg of oral finasteride. Arch Dermatol 138:543\u2013544","journal-title":"Arch Dermatol"},{"key":"1835_CR47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5858\/2000-124-0625-CAIAYO","volume":"124","author":"RL Zimmerman","year":"2000","unstructured":"Zimmerman RL, Fogt F, Cronin D, Lynch R (2000) Cytologic atypia in a 53-year-old man with finasteride-induced gynecomastia. Arch Pathol Lab Med 124:625\u2013627","journal-title":"Arch Pathol Lab Med"},{"key":"1835_CR48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-5347(01)64536-1","volume":"158","author":"BI Carlin","year":"1997","unstructured":"Carlin BI, Seftel AD, Resnick MI, Findlay J (1997) Finasteride induced gynecomastia. J Urol 158:547","journal-title":"J Urol"},{"key":"1835_CR49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02043907","volume":"4","author":"L Rossi","year":"1983","unstructured":"Rossi L, Bonuccelli U, Marcacci G et al (1983) Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports. Ital J Neurol Sci 4:207\u2013210","journal-title":"Ital J Neurol Sci"},{"key":"1835_CR50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1468-3083.2003.00519_9.x","volume":"17","author":"A Boulenger","year":"2003","unstructured":"Boulenger A, Viseux V, Plantin-Eon I et al (2003) Gynaecomastia following treatment by fluoxetine. J Eur Acad Dermatol Venereol 17:109","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1835_CR51","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1E517","volume":"39","author":"M Sahin","year":"2005","unstructured":"Sahin M, Yilmaz H, Guvener ND (2005) A possible case of gynecomastia with fluoxetine. Ann Pharmacother 39:1369","journal-title":"Ann Pharmacother"},{"key":"1835_CR52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0885-3924(00)00165-2","volume":"20","author":"Z Zylicz","year":"2000","unstructured":"Zylicz Z (2000) Painful gynecomastia: an unusual toxicity of gabapentin? J Pain Symptom Manage 20:2\u20133","journal-title":"J Pain Symptom Manage"},{"key":"1835_CR53","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/088922203769232539","volume":"19","author":"T Garcia-Benayas","year":"2003","unstructured":"Garcia-Benayas T, Blanco F, Martin-Carbonero L et al (2003) Gynecomastia in HIV-infected patients receiving antiretroviral therapy. AIDS Res Hum Retroviruses 19:739\u2013741","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1835_CR54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-107-2-257_1","volume":"107","author":"LJ Couderc","year":"1987","unstructured":"Couderc LJ, Clauvel JP (1987) HIV-infection-induced gynecomastia. Ann Intern Med 107:257","journal-title":"Ann Intern Med"},{"key":"1835_CR55","first-page":"2232","volume":"12","author":"D Schurmann","year":"1998","unstructured":"Schurmann D, Bergmann F, Ehrenstein T, Padberg J (1998) Gynaecomastia in a male patient during protease inhibitor treatment for acute HIV disease. AIDS 12:2232\u20132233","journal-title":"AIDS"},{"key":"1835_CR56","first-page":"242","volume":"15","author":"A Chalazonitis","year":"2009","unstructured":"Chalazonitis A, Sotiropoulou E, Ptohis N et al (2009) HIV-infected hemophilia a patient presenting with gynecomastia. Diagn Interv Radiol 15:242\u2013246","journal-title":"Diagn Interv Radiol"},{"key":"1835_CR57","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1086\/343045","volume":"35","author":"DL Evans","year":"2002","unstructured":"Evans DL, Pantanowitz L, Dezube BJ, Aboulafia DM (2002) Breast enlargement in 13 men who were seropositive for human immunodeficiency virus. Clin Infect Dis 35:1113\u20131119","journal-title":"Clin Infect Dis"},{"key":"1835_CR58","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/00002030-200205240-00019","volume":"16","author":"V Paech","year":"2002","unstructured":"Paech V, Lorenzen T, von Krosigk A et al (2002) Gynaecomastia in HIV-infected men: association with effects of antiretroviral therapy. AIDS 16:1193\u20131195","journal-title":"AIDS"},{"key":"1835_CR59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/00365540110026476","volume":"33","author":"L Piroth","year":"2001","unstructured":"Piroth L, Grappin M, Petit JM et al (2001) Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy. Scand J Infect Dis 33:559\u2013560","journal-title":"Scand J Infect Dis"},{"key":"1835_CR60","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/135965350400900416","volume":"9","author":"JA Mira","year":"2004","unstructured":"Mira JA, Lozano F, Santos J et al (2004) Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment. Antivir Ther 9:511\u2013517","journal-title":"Antivir Ther"},{"key":"1835_CR61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00126334-200401010-00017","volume":"35","author":"R Manfredi","year":"2004","unstructured":"Manfredi R, Calza L, Chiodo F (2004) Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones. J Acquir Immune Defic Syndr 35:99\u2013102","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1835_CR62","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00002030-200406180-00019","volume":"18","author":"C Strub","year":"2004","unstructured":"Strub C, Kaufmann GR, Flepp M et al (2004) Gynecomastia and potent antiretroviral therapy. AIDS 18:1347\u20131349","journal-title":"AIDS"},{"key":"1835_CR63","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1097\/00002030-199910220-00022","volume":"13","author":"H Peyriere","year":"1999","unstructured":"Peyriere H, Mauboussin JM, Rouanet I et al (1999) Report of gynecomastia in five male patients during antiretroviral therapy for HIV infection. AIDS 13:2167\u20132169","journal-title":"AIDS"},{"key":"1835_CR64","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0140-6736(03)13554-4","volume":"361","author":"C Gambacorti-Passerini","year":"2003","unstructured":"Gambacorti-Passerini C, Tornaghi L, Cavagnini F et al (2003) Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet 361:1954\u20131956","journal-title":"Lancet"},{"key":"1835_CR65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-230X-11-116","volume":"11","author":"H Liu","year":"2011","unstructured":"Liu H, Liao G, Yan Z (2011) Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event. BMC Gastroenterol 11:116. doi: 10.1007\/s00228-015-1835-x","journal-title":"BMC Gastroenterol"},{"key":"1835_CR66","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1086\/517743","volume":"27","author":"JP Caeiro","year":"1998","unstructured":"Caeiro JP, Visnegarwala F, Rodriguez-Barradas MC (1998) Gynecomastia associated with indinavir therapy. Clin Infect Dis 27:1539\u20131540","journal-title":"Clin Infect Dis"},{"key":"1835_CR67","first-page":"681","volume":"12","author":"E Toma","year":"1998","unstructured":"Toma E, Therrien R (1998) Gynecomastia during indinavir antiretroviral therapy in HIV infection. AIDS 12:681\u2013682","journal-title":"AIDS"},{"key":"1835_CR68","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1590\/S1806-37132008001100014","volume":"34","author":"N Morrone","year":"2008","unstructured":"Morrone N, Morrone N Jr, Braz AG, Maia JA (2008) Gynecomastia: a rare adverse effect of isoniazid. J Bras Pneumol 34:978\u2013981","journal-title":"J Bras Pneumol"},{"key":"1835_CR69","first-page":"51","volume":"56","author":"R Garg","year":"2009","unstructured":"Garg R, Vaibhav, Mehra S, Prasad R (2009) Isoniazid induced gynaecomastia: a case report. Indian J Tuberc 56:51\u201354","journal-title":"Indian J Tuberc"},{"key":"1835_CR70","first-page":"277","volume":"45","author":"P Khanna","year":"2003","unstructured":"Khanna P, Panjabi C, Maurya V, Shah A (2003) Isoniazid associated, painful, bilateral gynaecomastia. Indian J Chest Dis Allied Sci 45:277\u2013279","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"1835_CR71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4046\/trd.2009.66.1.33","volume":"66","author":"MK Lee","year":"2009","unstructured":"Lee MK, Na DJ, Jeon HS, Lee YD, Cho YS, Han MS, Yoon HJ (2009) A case of isoniazid induced gynecomastia. Korean Acad Tuberc Respir Dis 66:33\u201336","journal-title":"Korean Acad Tuberc Respir Dis"},{"key":"1835_CR72","first-page":"978","volume":"34","author":"N Morrone","year":"2008","unstructured":"Morrone N, Morrone N Jr, Braz AG, Maia JAF (2008) Gynecomastia: a rare adverse effect of isoniazid. Tisilogia 34:978\u2013981","journal-title":"Tisilogia"},{"key":"1835_CR73","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.19.6.1073","volume":"19","author":"R DeFelice","year":"1981","unstructured":"DeFelice R, Johnson DG, Galgiani JN (1981) Gynecomastia with ketoconazole. Antimicrob Agents Chemother 19:1073\u20131074","journal-title":"Antimicrob Agents Chemother"},{"key":"1835_CR74","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0002-9343(82)90480-6","volume":"72","author":"R DeFelice","year":"1982","unstructured":"DeFelice R, Galgiani JN, Campbell SC et al (1982) Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study. Am J Med 72:681\u2013687","journal-title":"Am J Med"},{"key":"1835_CR75","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2006.02.003","volume":"120","author":"RC Allen","year":"2007","unstructured":"Allen RC, Wallace AM, Royce M (2007) Marinol-induced gynecomastia: a case report. Am J Med 120:e1","journal-title":"Am J Med"},{"key":"1835_CR76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/s10165-007-0619-2","volume":"17","author":"K Abe","year":"2007","unstructured":"Abe K, Mitsuka T, Kanamori S et al (2007) Gynecomastia associated with low-dose methotrexate therapy for rheumatoid arthritis. Mod Rheumatol 17:511\u2013513","journal-title":"Mod Rheumatol"},{"key":"1835_CR77","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2230.2005.01925.x","volume":"31","author":"D Pandhi","year":"2006","unstructured":"Pandhi D, Gupta R, Singal A (2006) Gynaecomastia with oligospermia: an unusual complication of low-dose methotrexate for pustular psoriasis. Clin Exp Dermatol 31:138\u2013140","journal-title":"Clin Exp Dermatol"},{"key":"1835_CR78","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1001\/jama.1985.03360220083034","volume":"254","author":"TC Fagan","year":"1985","unstructured":"Fagan TC, Johnson DG, Grosso DS (1985) Metronidazole-induced gynecomastia. JAMA 254:3217","journal-title":"JAMA"},{"key":"1835_CR79","first-page":"U2803","volume":"120","author":"M Sahin","year":"2007","unstructured":"Sahin M, Yilmaz H, Gursoy A et al (2007) Gynaecomastia in a man and hyperoestrogenism in a woman due to ingestion of nettle (Urtica dioica). N Z Med J 120:U2803","journal-title":"N Z Med J"},{"key":"1835_CR80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/bmj.292.6517.380","volume":"292","author":"CAC Clyne","year":"1986","unstructured":"Clyne CAC (1986) Unreviewed reports: unilateral gynecomastia and nifedipine. Br Med J (Clin Res Ed) 292:380","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1835_CR81","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2165\/00002018-200730060-00006","volume":"30","author":"A Carvajal","year":"2007","unstructured":"Carvajal A, Macias D, Gutierrez A et al (2007) Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System. Drug Saf 30:527\u2013531","journal-title":"Drug Saf"},{"key":"1835_CR82","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0140-6736(91)92018-W","volume":"338","author":"C Convens","year":"1991","unstructured":"Convens C, Verhelst J, Mahler C (1991) Painful gynaecomastia during omeprazole therapy. Lancet 338:1153","journal-title":"Lancet"},{"key":"1835_CR83","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4088\/JCP.v64n0819c","volume":"64","author":"C Damsa","year":"2003","unstructured":"Damsa C, Sterck R, Schulz P (2003) Case of gynecomastia during paroxetine therapy. J Clin Psychiatry 64:971","journal-title":"J Clin Psychiatry"},{"key":"1835_CR84","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.65.5.803b","volume":"65","author":"A Ikeda","year":"1998","unstructured":"Ikeda A, Hattori H, Odani A et al (1998) Gynaecomastia in association with phenytoin and zonisamide in a patient having a CYP2C subfamily mutation. J Neurol Neurosurg Psychiatry 65:803\u2013804","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1835_CR85","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.294.6572.612","volume":"294","author":"JP Monson","year":"1987","unstructured":"Monson JP, Scott DF (1987) Gynaecomastia induced by phenytoin in men with epilepsy. Br Med J (Clin Res Ed) 294:612","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1835_CR86","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1528-1167.2006.00713.x","volume":"47","author":"I Malaga","year":"2006","unstructured":"Malaga I, Sanmarti FX (2006) Two cases of painful gynecomastia and lower extremity pain in association with pregabalin therapy. Epilepsia 47:1576\u20131579","journal-title":"Epilepsia"},{"key":"1835_CR87","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(82)91128-X","volume":"2","author":"S Tosi","year":"1982","unstructured":"Tosi S, Cagnoli M (1982) Painful gynecomastia with ranitidine. Lancet 2:160","journal-title":"Lancet"},{"key":"1835_CR88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1592\/phco.28.4.549","volume":"28","author":"A Oteri","year":"2008","unstructured":"Oteri A, Catania MA, Travaglini R et al (2008) Gynecomastia possibly induced by rosuvastatin. Pharmacotherapy 28:549\u2013551","journal-title":"Pharmacotherapy"},{"key":"1835_CR89","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2265.2010.03802.x","volume":"73","author":"MK Picolos","year":"2010","unstructured":"Picolos MK, Zeniou V, Michalis A (2010) Rosuvastatin-induced gynaecomastia. Clin Endocrinol 73:421\u2013424","journal-title":"Clin Endocrinol"},{"key":"1835_CR90","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1258\/0956462991912935","volume":"10","author":"B Donovan","year":"1999","unstructured":"Donovan B, Bodsworth NJ, Mulhall BP, Allen D (1999) Gynaecomastia associated with saquinavir therapy. Int J STD AIDS 10:49\u201350","journal-title":"Int J STD AIDS"},{"key":"1835_CR91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1258\/0956462991913934","volume":"10","author":"JJ Post","year":"1999","unstructured":"Post JJ (1999) Gynaecomastia associated with combination antiretroviral therapy including protease inhibitors for human immunodeficiency virus infection. Int J STD AIDS 10:275\u2013276","journal-title":"Int J STD AIDS"},{"key":"1835_CR92","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jcem-45-2-255","volume":"45","author":"R Caminos-Torres","year":"1977","unstructured":"Caminos-Torres R, Ma L, Snyder PJ (1977) Gynecomastia and semen abnormalities induced by spironolactone in normal men. J Clin Endocrinol Metab 45:255\u2013260. doi: 10.1007\/s00228-015-1835-x","journal-title":"J Clin Endocrinol Metab"},{"key":"1835_CR93","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(86)92856-4","volume":"1","author":"G Bellati","year":"1986","unstructured":"Bellati G, Ideo G (1986) Gynaecomastia after spironolactone and potassium canrenoate. Lancet 1:626","journal-title":"Lancet"},{"key":"1835_CR94","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-87-4-398","volume":"87","author":"LI Rose","year":"1977","unstructured":"Rose LI, Underwood RH, Newmark SR et al (1977) Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med 87:398\u2013403","journal-title":"Ann Intern Med"},{"key":"1835_CR95","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709\u2013717","journal-title":"N Engl J Med"},{"key":"1835_CR96","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","volume":"60","author":"X Jeunemaitre","year":"1987","unstructured":"Jeunemaitre X, Chatellier G, Kreft-Jais C et al (1987) Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 60:820\u2013825","journal-title":"Am J Cardiol"},{"key":"1835_CR97","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jama.1973.03220010068036","volume":"223","author":"DJ Greenblatt","year":"1973","unstructured":"Greenblatt DJ, Koch-Weser J (1973) Gynecomastia and impotence: complications of spironolactone therapy. JAMA 223:82","journal-title":"JAMA"},{"key":"1835_CR98","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/jcem-41-4-777","volume":"41","author":"B Stripp","year":"1975","unstructured":"Stripp B, Taylor AA, Bartter FC et al (1975) Effect of spironolactone on sex hormones in man. J Clin Endocrinol Metab 41:777\u2013781","journal-title":"J Clin Endocrinol Metab"},{"key":"1835_CR99","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4065\/84.8.672","volume":"84","author":"BA Haynes","year":"2009","unstructured":"Haynes BA, Mookadam F (2009) Male gynecomastia. Mayo Clin Proc 84:672","journal-title":"Mayo Clin Proc"},{"key":"1835_CR100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/mds.21579","volume":"22","author":"HA Teive","year":"2007","unstructured":"Teive HA, Munhoz RP, Werneck LC (2007) Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure. Mov Disord 22:1678\u20131679","journal-title":"Mov Disord"},{"key":"1835_CR101","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1345\/aph.17243a","volume":"32","author":"KM Melbourne","year":"1998","unstructured":"Melbourne KM, Brown SL, Silverblatt FJ (1998) Gynecomastia with stavudine treatment in an HIV-positive patient. Ann Pharmacother 32:1108","journal-title":"Ann Pharmacother"},{"key":"1835_CR102","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.1983.03340170022012","volume":"250","author":"A Kapoor","year":"1983","unstructured":"Kapoor A, Gopalakrishnan L, Weis S (1983) Reversible gynecomastia associated with sulindac therapy. JAMA 250:2284\u20132285","journal-title":"JAMA"},{"key":"1835_CR103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2710.2002.00378.x","volume":"27","author":"Y Kaneda","year":"2002","unstructured":"Kaneda Y, Fujii A (2002) Gynecomastia with sulpiride. J Clin Pharm Ther 27:75\u201377","journal-title":"J Clin Pharm Ther"},{"key":"1835_CR104","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00044011-200929070-00007","volume":"29","author":"P Ballardini","year":"2009","unstructured":"Ballardini P, Margutti G, Aliberti C, Manfredini R (2009) Onset of male gynaecomastia in a patient treated with sunitinib for metastatic renal cell carcinoma. Clin Drug Investig 29:487\u2013490","journal-title":"Clin Drug Investig"},{"key":"1835_CR105","first-page":"152","volume":"26","author":"Y Kaneda","year":"2001","unstructured":"Kaneda Y, Morimoto T, Fujii A (2001) Gynecomastia induced by treatment with tandospirone, a 5-HT1A agonist. J Psychiatry Neurosci 26:152\u2013153","journal-title":"J Psychiatry Neurosci"},{"key":"1835_CR106","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajh.10128","volume":"70","author":"M Pulik","year":"2002","unstructured":"Pulik M, Genet P, Lionnet F, Touahri T (2002) Thalidomide-associated gynecomasty in a patient with multiple myeloma. Am J Hematol 70:265","journal-title":"Am J Hematol"},{"key":"1835_CR107","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.thj.6200296","volume":"4","author":"YA Mourad","year":"2003","unstructured":"Mourad YA, Shamseddine A, Taher A (2003) Thalidomide-associated gynecomasty in a patient with multiple myeloma. Hematol J 4:372","journal-title":"Hematol J"},{"key":"1835_CR108","first-page":"141","volume":"18","author":"KR Dardick","year":"1984","unstructured":"Dardick KR (1984) Gynecomastia associated with theophylline. J Fam Pract 18:141\u2013142","journal-title":"J Fam Pract"},{"key":"1835_CR109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/WNF.0b013e3181679126","volume":"32","author":"F Karakurt","year":"2009","unstructured":"Karakurt F, Kargili A, Uz B et al (2009) Venlafaxine-induced gynecomastia in a young patient: a case report. Clin Neuropharmacol 32:51\u201352","journal-title":"Clin Neuropharmacol"},{"key":"1835_CR110","first-page":"347","volume":"107","author":"RH Smith","year":"1967","unstructured":"Smith RH, Barrett O Jr (1967) Gynecomastia associated with vincristine therapy. Calif Med 107:347\u2013349","journal-title":"Calif Med"},{"key":"1835_CR111","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/art.1780260523","volume":"26","author":"DW Paine Del","year":"1983","unstructured":"Del Paine DW, Leek JC, Jakle C, Robbins DL (1983) Gynecomastia associated with low dose methotrexate therapy. Arthritis Rheum 26:691\u2013692","journal-title":"Arthritis Rheum"},{"key":"1835_CR112","first-page":"635","volume":"324","author":"L Santucci","year":"1991","unstructured":"Santucci L, Farroni F, Fiorucci S, Morelli A (1991) Gynecomastia during omeprazole therapy. N Engl J Med 324:635","journal-title":"N Engl J Med"},{"key":"1835_CR113","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ajcp\/57.4.431","volume":"57","author":"GA Bannayan","year":"1972","unstructured":"Bannayan GA, Hajdu SI (1972) Gynecomastia: clinicopathologic study of 351 cases. Am J Clin Pathol 57:431\u2013437","journal-title":"Am J Clin Pathol"},{"key":"1835_CR114","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000326501","volume":"47","author":"EA Allen","year":"2003","unstructured":"Allen EA, Parwani AV, Siddiqui MT et al (2003) Cytopathologic findings in breast masses in men with HIV infection. Acta Cytol 47:183\u2013187","journal-title":"Acta Cytol"},{"key":"1835_CR115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM198908033210501","volume":"321","author":"RA Galbraith","year":"1989","unstructured":"Galbraith RA, Michnovicz JJ (1989) The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med 321:269\u2013274","journal-title":"N Engl J Med"},{"key":"1835_CR116","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","volume":"49","author":"N Chapman","year":"2007","unstructured":"Chapman N, Dobson J, Wilson S et al (2007) Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49:839\u2013845","journal-title":"Hypertension"},{"key":"1835_CR117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000199905","volume":"44","author":"A Andriulli","year":"1989","unstructured":"Andriulli A, Arrigoni A, Gindro T et al (1989) Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy. Digestion 44:155\u2013162","journal-title":"Digestion"},{"key":"1835_CR118","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.1982.03320340049034","volume":"247","author":"DC Cumming","year":"1982","unstructured":"Cumming DC, Yang JC, Rebar RW, Yen SS (1982) Treatment of hirsutism with spironolactone. JAMA 247:1295\u20131298","journal-title":"JAMA"},{"key":"1835_CR119","author":"MJ Williams","year":"1963","unstructured":"Williams MJ (1963) Gynecomastia. Its incidence, recognition and host characterization in 447 autopsy cases. Am J Med. doi: 10.1007\/s00228-015-1835-x","journal-title":"Am J Med"},{"key":"1835_CR120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0002-9343(63)90044-5","volume":"34","author":"MJ Williams","year":"1963","unstructured":"Williams MJ (1963) Gynecomastia. Its incidence, recognition and host characterization in 447 autopsy cases. Am J Med 34:103\u2013112","journal-title":"Am J Med"},{"key":"1835_CR121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-32-2-173","volume":"32","author":"GL Nicolis","year":"1971","unstructured":"Nicolis GL, Modlinger RS, Gabrilove JL (1971) A study of the histopathology of human gynecomastia. J Clin Endocrinol Metab 32:173\u2013178","journal-title":"J Clin Endocrinol Metab"},{"key":"1835_CR122","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/1097-0142(195811\/12)11:6<1083::AID-CNCR2820110602>3.0.CO;2-9","volume":"11","author":"N Treves","year":"1958","unstructured":"Treves N (1958) Gynecomastia; the origins of mammary swelling in the male: an analysis of 406 patients with breast hypertrophy, 525 with testicular tumors, and 13 with adrenal neoplasms. Cancer 11:1083\u20131102","journal-title":"Cancer"},{"key":"1835_CR123","first-page":"296","volume":"72","author":"DJ Jones","year":"1990","unstructured":"Jones DJ, Holt SD, Surtees P et al (1990) A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients. Ann R Coll Surg Engl 72:296\u2013298. doi: 10.1007\/s00228-015-1835-x","journal-title":"Ann R Coll Surg Engl"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1835-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1835-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1835-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:40:40Z","timestamp":1651624840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1835-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":123,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1835"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1835-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}